Prio Wealth Limited Partnership Abbott Laboratories Transaction History

Prio Wealth Limited Partnership

$3.38 Billion
Q3 2024

A detailed history of Prio Wealth Limited Partnership transactions in Abbott Laboratories stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 483,269 shares of ABT stock, worth $56 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares

483,269

Previous 486,490 0.66%

Holding current value

$56 Million

Previous $50.6 Million 8.99%

% of portfolio

1.63%

Previous 1.52%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$100.07 - $118.13 $322,325 - $380,496	-3,221 Reduced 0.66%	483,269 $55.1 Million
Q2 2024 Sep 10, 2024	SELL	$100.73 - $112.44 $5.55 Million - $6.2 Million	-55,147 Reduced 10.18%	486,490 $50.6 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $4.63 Million - $5.11 Million	42,257 Added 8.46%	541,637 $61.6 Million
Q4 2023 Jan 22, 2024	SELL	$90.19 - $110.4 $581,184 - $711,417	-6,444 Reduced 1.27%	499,380 $55 Million
Q3 2023 Oct 31, 2023	SELL	$95.53 - $114.62 $1.17 Million - $1.4 Million	-12,250 Reduced 2.36%	505,824 $49 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $704,049 - $784,457	-6,986 Reduced 1.33%	518,074 $56.5 Million
Q1 2023 May 12, 2023	SELL	$96.86 - $114.01 $5.77 Million - $6.79 Million	-59,546 Reduced 10.19%	525,060 $53.2 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $9.04 Million - $10.6 Million	-95,058 Reduced 13.99%	584,606 $0
Q3 2022 Feb 27, 2023	SELL	$96.76 - $112.03 $1.9 Million - $2.2 Million	-19,633 Reduced 3.07%	619,686 $60 Million
Q2 2022 Feb 27, 2023	BUY	$102.07 - $123.37 $5.58 Million - $6.75 Million	54,713 Added 9.36%	639,319 $69.5 Million
Q1 2022 Feb 21, 2023	BUY	$114.02 - $139.04 $10.7 Million - $13 Million	93,418 Added 15.98%	678,024 $80.3 Million
Q4 2021 Feb 17, 2022	SELL	$115.53 - $141.46 $1.01 Million - $1.23 Million	-8,723 Reduced 1.27%	679,664 $95.7 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $1.03 Million - $1.14 Million	-8,840 Reduced 1.27%	688,387 $81.3 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $3.53 Million - $4.16 Million	-33,410 Reduced 4.57%	697,227 $80.8 Million
Q1 2021 May 06, 2021	SELL	$108.84 - $128.23 $2.68 Million - $3.15 Million	-24,599 Reduced 3.26%	730,637 $87.6 Million
Q4 2020 Feb 04, 2021	SELL	$105.0 - $114.42 $1.17 Million - $1.28 Million	-11,176 Reduced 1.46%	755,236 $82.7 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $887,625 - $1.08 Million	9,686 Added 1.28%	766,412 $83.4 Million
Q2 2020 Aug 11, 2020	BUY	$76.57 - $98.0 $97,320 - $124,558	1,271 Added 0.17%	756,726 $69.2 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $959,952 - $1.4 Million	-15,281 Reduced 1.98%	755,455 $59.6 Million
Q4 2019 Feb 10, 2020	SELL	$78.51 - $87.4 $1.35 Million - $1.5 Million	-17,188 Reduced 2.18%	770,736 $66.9 Million
Q3 2019 Nov 13, 2019	SELL	$81.84 - $88.74 $4.02 Million - $4.36 Million	-49,101 Reduced 5.87%	787,924 $65.9 Million
Q2 2019 Jul 18, 2019	SELL	$72.88 - $85.0 $2.97 Million - $3.46 Million	-40,685 Reduced 4.64%	837,025 $70.4 Million
Q1 2019 May 03, 2019	SELL	$66.22 - $80.06 $1.92 Million - $2.33 Million	-29,061 Reduced 3.2%	877,710 $70.2 Million
Q4 2018 Feb 06, 2019	SELL	$65.56 - $74.27 $398,867 - $451,858	-6,084 Reduced 0.67%	906,771 $65.6 Million
Q3 2018 Nov 07, 2018	BUY	$60.81 - $73.36 $453,520 - $547,118	7,458 Added 0.82%	912,855 $67 Million
Q2 2018 Aug 06, 2018	SELL	$57.57 - $63.54 $1.17 Million - $1.29 Million	-20,274 Reduced 2.19%	905,397 $55.2 Million
Q1 2018 Apr 17, 2018	BUY	$56.27 - $63.62 $52.1 Million - $58.9 Million	925,671 New	925,671 $55.5 Million

Others Institutions Holding ABT

# of Institutions

3,184

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $203B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.

Account

Prio Wealth Limited Partnership Abbott Laboratories Transaction History